GO ID | Source | Type | Description |
GO:0005829 |
TAS:Reactome | C | cytosol |
GO:0016020 |
IDA:RGD | C | membrane |
GO:0043005 |
IDA:RGD | C | neuron projection |
GO:0005634 |
IDA:RGD | C | nucleus |
GO:0005942 |
IDA:RGD | C | phosphatidylinositol 3-kinase complex |
GO:0005943 |
ISS:UniProtKB | C | phosphatidylinositol 3-kinase complex, class IA |
GO:0005886 |
IDA:RGD | C | plasma membrane |
GO:0043234 |
IDA:RGD | C | protein complex |
GO:0016303 |
TAS:RGD | F | 1-phosphatidylinositol-3-kinase activity |
GO:0046935 |
IDA:RGD | F | 1-phosphatidylinositol-3-kinase regulator activity |
GO:0051117 |
IPI:RGD | F | ATPase binding |
GO:0005516 |
IPI:RGD | F | calmodulin binding |
GO:0043125 |
ISS:UniProtKB | F | ErbB-3 class receptor binding |
GO:0030331 |
IPI:RGD | F | estrogen receptor binding |
GO:0005159 |
ISS:UniProtKB | F | insulin-like growth factor receptor binding |
GO:0005158 |
ISS:UniProtKB | F | insulin receptor binding |
GO:0043560 |
ISS:UniProtKB | F | insulin receptor substrate binding |
GO:0043548 |
IPI:RGD | F | phosphatidylinositol 3-kinase binding |
GO:0035014 |
ISS:UniProtKB | F | phosphatidylinositol 3-kinase regulator activity |
GO:0051219 |
IPI:RGD | F | phosphoprotein binding |
GO:0005161 |
IPI:RGD | F | platelet-derived growth factor receptor binding |
GO:0008022 |
IDA:RGD | F | protein C-terminus binding |
GO:0019904 |
IPI:RGD | F | protein domain specific binding |
GO:0019901 |
IPI:RGD | F | protein kinase binding |
GO:0005102 |
IPI:RGD | F | receptor binding |
GO:0030971 |
IPI:RGD | F | receptor tyrosine kinase binding |
GO:0031625 |
IPI:RGD | F | ubiquitin protein ligase binding |
GO:0007568 |
IEP:RGD | P | aging |
GO:0071398 |
IEP:RGD | P | cellular response to fatty acid |
GO:0032869 |
IEP:RGD | P | cellular response to insulin stimulus |
GO:0006006 |
IMP:RGD | P | glucose metabolic process |
GO:0048009 |
ISS:UniProtKB | P | insulin-like growth factor receptor signaling pathway |
GO:0008286 |
ISS:UniProtKB | P | insulin receptor signaling pathway |
GO:0045776 |
IMP:RGD | P | negative regulation of blood pressure |
GO:0022408 |
IMP:RGD | P | negative regulation of cell-cell adhesion |
GO:0010459 |
IMP:RGD | P | negative regulation of heart rate |
GO:0010656 |
IMP:RGD | P | negative regulation of muscle cell apoptotic process |
GO:0045861 |
IMP:RGD | P | negative regulation of proteolysis |
GO:0048662 |
IMP:RGD | P | negative regulation of smooth muscle cell proliferation |
GO:0036092 |
IDA:GOC | P | phosphatidylinositol-3-phosphate biosynthetic process |
GO:0046854 |
ISS:UniProtKB | P | phosphatidylinositol phosphorylation |
GO:0030335 |
IMP:RGD | P | positive regulation of cell migration |
GO:0010628 |
IMP:RGD | P | positive regulation of gene expression |
GO:0045663 |
IMP:RGD | P | positive regulation of myoblast differentiation |
GO:0001934 |
IMP:RGD | P | positive regulation of protein phosphorylation |
GO:0043551 |
IDA:RGD | P | regulation of phosphatidylinositol 3-kinase activity |
GO:0043200 |
IEP:RGD | P | response to amino acid |
GO:0051591 |
IDA:RGD | P | response to cAMP |
GO:0071548 |
IEP:RGD | P | response to dexamethasone |
GO:0042493 |
IEP:RGD | P | response to drug |
GO:0032355 |
IEP:RGD | P | response to estradiol |
GO:0045471 |
IEP:RGD | P | response to ethanol |
GO:0070542 |
IEP:RGD | P | response to fatty acid |
GO:0009750 |
IEP:RGD | P | response to fructose |
GO:0051384 |
IDA:RGD | P | response to glucocorticoid |
GO:0070848 |
IEP:RGD | P | response to growth factor |
GO:0032868 |
IDA:RGD | P | response to insulin |
GO:0010040 |
IEP:RGD | P | response to iron(II) ion |
GO:0007584 |
IEP:RGD | P | response to nutrient |
GO:0032570 |
IEP:RGD | P | response to progesterone |
GO:0033574 |
IEP:RGD | P | response to testosterone |
GO:0001878 |
IEP:RGD | P | response to yeast |
REACTOME Pathway ID | Description |
---|
5953415 | Adaptive Immune System |
5953413 | Antigen activates B Cell Receptor (BCR) leading to generation of second messengers |
5953991 | CD28 co-stimulation |
5953990 | CD28 dependent PI3K/Akt signaling |
5954063 | Cell-Cell communication |
5953650 | Cell surface interactions at the vascular wall |
5954570 | Constitutive PI3K/AKT Signaling in Cancer |
5953992 | Costimulation by the CD28 family |
5953536 | Cytokine Signaling in Immune system |
5953408 | DAP12 interactions |
5953407 | DAP12 signaling |
5953253 | Disease |
5953994 | Downstream signaling events of B Cell Receptor (BCR) |
5953399 | Downstream signaling of activated FGFR |
5953396 | Downstream signal transduction |
5954035 | Downstream TCR signaling |
5953417 | Fc epsilon receptor (FCERI) signaling |
5953784 | Fcgamma receptor (FCGR) dependent phagocytosis |
5953884 | GAB1 signalosome |
5953641 | G alpha (12/13) signalling events |
5953653 | G alpha (q) signalling events |
5953537 | Gastrin-CREB signalling pathway via PKC and MAPK |
5954278 | GP1b-IX-V activation signalling |
5953642 | GPCR downstream signaling |
5953651 | GPVI-mediated activation cascade |
5953645 | Hemostasis |
5953430 | IGF1R signaling cascade |
5953410 | Immune System |
5953409 | Innate Immune System |
5953422 | Insulin receptor signalling cascade |
5953534 | Interleukin-2 signaling |
5954001 | Interleukin-3, 5 and GM-CSF signaling |
5954308 | Interleukin-7 signaling |
5954000 | Interleukin receptor SHC signaling |
5953428 | IRS-mediated signalling |
5953425 | IRS-related events |
5953429 | IRS-related events triggered by IGF1R |
5953250 | Metabolism |
5953289 | Metabolism of lipids and lipoproteins |
5954128 | Nephrin interactions |
5953394 | NGF signalling via TRKA from the plasma membrane |
5953474 | Phospholipid metabolism |
5953989 | PI3K/AKT activation |
5953997 | PI3K/AKT Signaling in Cancer |
5953885 | PI-3K cascade |
5953432 | PI3K Cascade |
5953996 | PI3K events in ERBB2 signaling |
5953995 | PI3K events in ERBB4 signaling |
5954478 | PI Metabolism |
5953993 | PIP3 activates AKT signaling |
5953644 | Platelet activation, signaling and aggregation |
5954358 | Regulation of signaling by CBL |
5953998 | Role of LAT2/NTAL/LAB on calcium mobilization |
5953783 | Role of phospholipids in phagocytosis |
5954412 | Signaling by constitutively active EGFR |
5953403 | Signaling by EGFR |
5953404 | Signaling by EGFR in Cancer |
5953406 | Signaling by ERBB2 |
5953540 | Signaling by ERBB4 |
5953400 | Signaling by FGFR |
5954510 | Signaling by FGFR1 fusion mutants |
5954511 | Signaling by FGFR1 mutants |
5953401 | Signaling by FGFR in disease |
5954512 | Signaling by FGFR mutants |
5953391 | Signaling by GPCR |
5953423 | Signaling by Insulin receptor |
5953535 | Signaling by Interleukins |
5953397 | Signaling by PDGF |
5953541 | Signaling by SCF-KIT |
5953414 | Signaling by the B Cell Receptor (BCR) |
5953431 | Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) |
5953420 | Signaling by VEGF |
5953395 | Signalling by NGF |
5953381 | Signal Transduction |
5954499 | Synthesis of PIPs at the plasma membrane |
5954036 | TCR signaling |
5954054 | Tie2 Signaling |
5953419 | VEGFA-VEGFR2 Pathway |